A review of the latest evidence surrounding the use of mycophenolate mofetil (MMF) as a maintenance therapy for patients in the remission phase of an ANCA-associated vasculitis with renal involvement.







**************************************

Estimated Time to View: 20 minutes
Title: Mycophenolate versus Azathioprine for maintenance in ANCA-associated vasculitis: The IMPROVE trial
Author: Reginald Obi, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2011
Date Created: 2011
Revisions: None Indicated
Disclaimers: None
Resource Type: Video
Other: Presented at ECU Journal Club on 10/18/11
Recommend to a Colleague/Friend

**************************************

LEARNING OPTIONS:

To view the interactive video, click here
To view this video using an iPad or iPhone, see below




Transparent Peer Review



GD Star Rating
loading...



To learn more about our 6-point transparent peer review system, click here



Mycophenolate versus Azathioprine for maintenance in ANCA-associated vasculitis: The IMPROVE trial, 9.0 out of 10 based on 2 ratings
Share

Comments

  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in General Nephrology, Glomerulonephritides (33 of 212 articles)